PATENT CLAIM ANALYSIS

Application Number: 16027503
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["544", "277000"]

Abstract:
Provided herein are formulations, solid forms and methods of use relating to (1s,4s)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide.

Claim (Index 18):
The method of  claim 16 , further comprising an EGFR mutation or increased EGFR activity.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15475836', '14945147', '15856845', '15004034', '13962745']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7318533076503035
- 35 USC 102 Novelty (BERT): 0.55619998499575
- Combined Prediction Score: 0.7142879753848482
- Mean Citation Score: 326.13321
- Max Citation Score: 455.79407
- Similarity Product: 293.8507587219363

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test